Satellite Symposium Discusses Long-Term Outcomes for MPS IVA and VI Patients
qimono / Pixabay

Satellite Symposium Discusses Long-Term Outcomes for MPS IVA and VI Patients

Yesterday, a group of experts presented "Changing lives: Long-term outcomes of MPS IVA & VI patients" at the Satellite Symposium sponsored by BioMarin. The program began with insights on the…

Continue Reading Satellite Symposium Discusses Long-Term Outcomes for MPS IVA and VI Patients
We’re On the Way to Treating an Untreatable Condition
Source: https://pixabay.com/en/cambodia-village-countryside-kid-2197176/

We’re On the Way to Treating an Untreatable Condition

Lysogene, a biopharmaceutical company, announced at the end of May that enrollment in SAMOS (Sanfilippo A Multinational Observational Study) was completed. This is extremely exciting news for Sanfilippo syndrome (MPS…

Continue Reading We’re On the Way to Treating an Untreatable Condition